Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis Pemphigus
This study is currently recruiting participants.
Verified March 2013 by University of California, Irvine
Study NCT01313923   Information provided by University of California, Irvine

First Received on March 10, 2011.   Last Updated on March 15, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pemphigus
Additional conditions recognized in this trial
Blister
Skin Diseases
More general conditions related to this trial
Autoimmune Diseases
Immune System Diseases
Pathological Conditions, Anatomical
Skin Diseases, Vesiculobullous
Additional drug interventions recognized in this trial
Everolimus
Sirolimus
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antineoplastic
Antifungal Agents
Antineoplastic Agents
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
University of California, Irvine


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services